Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4

Nature Communications

Volumn 7, Issue , 2016, Pages

  Gomez Rodriguez, Julio ^a   Meylan, Françoise ^b   Handon, Robin ^a   Hayes, Erika T ^b   Anderson, Stacie M ^a   Kirby, Martha R ^a   Siegel, Richard M ^b   Schwartzberg, Pamela L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; INTERLEUKIN 9; PAPAIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE ITK; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; EMT PROTEIN-TYROSINE KINASE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; PROTEIN KINASE; SMOK1 PROTEIN, MOUSE;

ASTHMA; BIOCHEMISTRY; CELLS AND CELL COMPONENTS; IMMUNE RESPONSE; INHIBITION; PROTEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LYMPHOID CELL; MOUSE; NONHUMAN; PNEUMONIA; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH9 CELL; ANIMAL; CHEMICALLY INDUCED; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LUNG DISEASE; MALE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; INTERFERON REGULATORY FACTORS; INTERLEUKIN-2; LUNG DISEASES; MALE; MICE; MICE, KNOCKOUT; PAPAIN; PROTEIN KINASES; PROTEIN-TYROSINE KINASES;

EID: 84960154765     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10857     Document Type: Article

References (70)

1. Kaplan, M. H., Hufford, M. M. & Olson, M. R. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15, 295-307 (2015).
2. Schmitt, E., Klein, M. & Bopp, T. Th9 cells, new players in adaptive immunity. Trends Immunol. 35, 61-68 (2014).
3. Erpenbeck, V. J. et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 111, 1319-1327 (2003).
4. Hoppenot, D. et al. Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients. Medicina (Kaunas) 51, 10-17 (2015).
5. Jones, C. P., Gregory, L. G., Causton, B., Campbell, G. A. & Lloyd, C. M. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J. Allergy Clin. Immunol. 129, 1000 (2012).
6. Shimbara, A. et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105, 108-115 (2000).
7. Sehra, S. et al. T9 cells are required for tissue mast cell accumulation during allergic inflammation. J. Allergy Clin. Immunol. 136, 433-440 (2015).
8. Chang, H. C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534 (2010).
9. Yao, W. et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38, 360-372 (2013).
10. Kearley, J. et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 183, 865-875 (2011).
11. Kung, T. T. et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 25, 600-605 (2001).
12. Cheng, G. et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166, 409-416 (2002).
13. Forbes, E. E. et al. IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913 (2008).
14. Temann, U. A., Geba, G. P., Rankin, J. A. & Flavell, R. A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307-1320 (1998).
15. Temann, U. A., Ray, P. & Flavell, R. A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29-39 (2002).
16. Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
17. Goswami, R. et al. STAT6-dependent regulation of Th9 development. J. Immunol. 188, 968-975 (2012).
18. Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
19. Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202 (2010).
20. Berg, L. J., Finkelstein, L. D., Lucas, J. A. & Schwartzberg, P. L. Tec family kinases in T lymphocyte development and function. Annu. Rev. Immunol. 23, 549-600 (2005).
21. Gomez-Rodriguez, J., Kraus, Z. J. & Schwartzberg, P. L. Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates. FEBS J. 278, 1980-1989 (2011).
22. Schaeffer, E. M. & Schwartzberg, P. L. Tec family kinases in lymphocyte signaling and function. Curr. Opin. Immunol. 12, 282-288 (2000).
23. Nayar, R. et al. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc. Natl. Acad. Sci. USA 109, E2794-E2802 (2012).
24. Man, K. et al. The transcription factor IRF4 is essential for TCR affinitymediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14, 1155-1165 (2013).
25. Yao, S. et al. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 39, 833-845 (2013).
26. Gomez-Rodriguez, J. et al. Differential expression of interleukin-17A and-17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 31, 587-597 (2009).
27. Gomez-Rodriguez, J. et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J. Exp. Med. 211, 529-543 (2014).
28. Fowell, D. J. et al. Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity 11, 399-409 (1999).
29. Schaeffer, E. M. et al. Mutation of Tec family kinases alters T helper cell differentiation. Nat. Immunol. 2, 1183-1188 (2001).
30. Mueller, C. & August, A. Attenuation of immunological symptoms of allergic asthma in mice lacking the tyrosine kinase ITK. J. Immunol. 170, 5056-5063 (2003).
31. Lee, S. H. et al. The association of a single-nucleotide polymorphism of the IL-2 inducible T-cell Kinase gene with asthma. Ann. Hum. Genet. 75, 359-369 (2011).
32. Au-Yeung, B. B. & Fowell, D. J. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J. Immunol. 179, 111-119 (2007).
33. Richard, A. C. et al. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J. Immunol. 194, 3567-3582 (2015).
34. Liao, X. C. & Littman, D. R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3, 757-769 (1995).
35. Liu, K. Q., Bunnell, S. C., Gurniak, C. B. & Berg, L. J. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187, 1721-1727 (1998).
36. Schaeffer, E. M. et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284, 638-641 (1999).
37. Broussard, C. et al. Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 25, 93-104 (2006).
38. Atherly, L. O. et al. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity 25, 79-91 (2006).
39. Hu, J. & August, A. Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development. J. Immunol. 180, 6544-6552 (2008).
40. Lin, T. A. et al. Selective Itk inhibitors block T-cell activation and murine lung inflammation. Biochemistry 43, 11056-11062 (2004).
41. Huang, W. & August, A. The signaling symphony: T cell receptor tunes cytokine-mediated T cell differentiation. J. Leukoc. Biol. 97, 477-485 (2015).
42. Srikanth, S. & Gwack, Y. Orai1-NFAT signalling pathway triggered by T cell receptor stimulation. Mol. Cells 35, 182-194 (2013).
43. Liao, W. et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc. Natl. Acad. Sci. USA 111, 3508-3513 (2014).
44. Bassil, R. et al. BCL6 controls Th9 cell development by repressing Il9 transcription. J. Immunol. 193, 198-207 (2014).
45. Schmitt, E. et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153, 3989-3996 (1994).
46. Voisinne, G. et al. T Cells integrate local and global cues to discriminate between structurally similar antigens. Cell Rep. 11, 1208-1219 (2015).
47. Yamane, H. & Paul, W. E. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol. Rev. 252, 12-23 (2013).
48. Halim, T. Y. et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425-435 (2014).
49. Kamijo, S. et al. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J. Immunol. 190, 4489-4499 (2013).
50. Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12, 1071-1077 (2011).
51. Oliphant, C. J. et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283-295 (2014).
52. Hardman, C. S., Panova, V. & McKenzie, A. N. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur. J. Immunol. 43, 488-498 (2013).
53. Schuurhof, A. et al. Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls. Pediatr. Pulmonol. 45, 608-613 (2010).
54. Fallon, P. G. et al. Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect. Immun. 68, 6005-6011 (2000).
55. Li, P., Spolski, R., Liao, W. & Leonard, W. J. Complex interactions of transcription factors in mediating cytokine biology in T cells. Immunol. Rev. 261, 141-156 (2014).
56. Xiao, X. et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat. Immunol. 13, 981-990 (2012).
57. Gessner, A., Blum, H. & Rollinghoff, M. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189, 419-435 (1993).
58. Jash, A. et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation. J. Biol. Chem. 287, 15445-15457 (2012).
59. Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127-2136 (1995).
60. Alam, M. S. et al. Counter-regulation of T cell effector function by differentially activated p38. J. Exp. Med. 211, 1257-1270 (2014).
61. Huber, M. & Lohoff, M. IRF4 at the crossroads of effector T-cell fate decision. Eur. J. Immunol. 44, 1886-1895 (2014).
62. Beadling, C. & Smith, K. A. DNA array analysis of interleukin-2-regulated immediate/early genes. Med. Immunol. 1, 2 (2002).
63. Niedbala, W. et al. Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nat. Commun. 5, 4575 (2014).
64. Lee, I. H., Li, W. P., Hisert, K. B. & Ivashkiv, L. B. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J. Exp. Med. 190, 1263-1274 (1999).
65. Feinerman, O. et al. Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol. Syst. Biol. 6, 437 (2010).
66. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
67. Johnston, R. J., Choi, Y. S., Diamond, J. A., Yang, J. A. & Crotty, S. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243-250 (2012).
68. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457-468 (2009).
69. Chen, C. H. et al. Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197, 1689-1699 (2003).
70. Sun, Y. et al. Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response. Sci. Signal. 8, ra122 (2015).